- Report
- July 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- March 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- April 2024
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2024
- 116 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2021
Global
From €2386EUR$2,500USD£1,999GBP
€4772EUR$5,000USD£3,998GBP
- Report
- December 2021
- 55 Pages
Global
- Report
- July 2023
- 180 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- November 2021
- 43 Pages
Global
- Report
- November 2022
- 117 Pages
Global
From €4295EUR$4,500USD£3,598GBP
The Genomic Platform market is a subset of the genomics industry that focuses on the development and commercialization of products and services related to the analysis of genomic data. This includes the development of software, hardware, and services that enable the analysis of genomic data, such as DNA sequencing, gene expression, and epigenetics. These products and services are used by researchers, clinicians, and other healthcare professionals to gain insights into the genetic basis of diseases, as well as to develop new treatments and diagnostics.
The Genomic Platform market is highly competitive, with a number of companies offering products and services. These include Illumina, Thermo Fisher Scientific, BGI, Oxford Nanopore Technologies, Pacific Biosciences, 10x Genomics, and GenapSys. Show Less Read more